Literature DB >> 28421481

Cancer as a Risk Factor for Cardiovascular Disease.

Dana Elena Giza1, Gloria Iliescu2, Saamir Hassan1, Konstantinos Marmagkiolis3,4, Cezar Iliescu5.   

Abstract

Improvements in early diagnosis and cancer treatments have contributed to high survival rates for many cancer patients. However, these patients often die of cardiovascular disease rather than recurrence of their cancer. Heart disease manifesting after cancer may be due to several mechanisms: shared cardiovascular risks between cancer and cardiovascular disease, inflammatory states associated with malignancies, and/or cardiotoxic effects of cancer therapy. Cancer treatment increases the risk of cardiovascular diseases directly by damaging critical structures of the heart or indirectly by promoting accelerated atherosclerosis. Estimating cardiovascular risk by using advanced imaging and monitoring of the cardiac biomarkers can be used for early detection and treatment of subclinical cardiac injury. Better knowledge of these early and late cardiac effects in cancer patients will enable adoption of both primary and secondary prevention measures of long-term treatment complications in cancer survivors.

Entities:  

Keywords:  Anthracyclines; Atherosclerosis; Cancer; Cardiac biomarkers; Cardiotoxicity; Cardiovascular disease; LVEF; Radiation; Risk factors

Mesh:

Substances:

Year:  2017        PMID: 28421481     DOI: 10.1007/s11912-017-0601-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  71 in total

Review 1.  Takotsubo cardiomyopathy and Fluorouracil: case report and review of the literature.

Authors:  Michael R Grunwald; Lynn Howie; Luis Alberto Diaz
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

Review 2.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

3.  The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

Authors:  Janine Nuver; Andries J Smit; Bruce H R Wolffenbuttel; Wim J Sluiter; Harald J Hoekstra; Dirk T Sleijfer; Jourik A Gietema
Journal:  J Clin Oncol       Date:  2005-02-28       Impact factor: 44.544

4.  Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience.

Authors:  J P Carrozza; R E Kuntz; M J Levine; R M Pomerantz; R F Fishman; M Mansour; C M Gibson; C C Senerchia; D J Diver; R D Safian
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

Review 5.  Atherothrombosis and high-risk plaque: part I: evolving concepts.

Authors:  Valentin Fuster; Pedro R Moreno; Zahi A Fayad; Roberto Corti; Juan J Badimon
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

Review 6.  Cancer drugs and the heart: importance and management.

Authors:  Thomas M Suter; Michael S Ewer
Journal:  Eur Heart J       Date:  2012-07-12       Impact factor: 29.983

7.  Nilotinib treatment-associated peripheral artery disease and sudden death: yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia.

Authors:  Ayalew Tefferi; Louis Letendre
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

Review 8.  Chemotherapy-induced takotsubo cardiomyopathy.

Authors:  Sakima A Smith; Alex J Auseon
Journal:  Heart Fail Clin       Date:  2013-01-23       Impact factor: 3.179

9.  A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.

Authors:  Christian Mueller; Helmut Roskamm; Franz-Josef Neumann; Patrick Hunziker; Stephan Marsch; André Perruchoud; Heinz J Buettner
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

10.  Takotsubo cardiomyopathy and 5-Fluorouracil: getting to the heart of the matter.

Authors:  Stephanie Hui-Su Lim; Sharon Mary Wilson; Arnagretta Hunter; Jane Hill; Philip Beale
Journal:  Case Rep Oncol Med       Date:  2013-12-03
View more
  14 in total

Review 1.  The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?

Authors:  Serban Mihai Balanescu; Dinu Valentin Balanescu; Teodora Donisan; Eric H Yang; Nicolas Palaskas; Juan Lopez-Mattei; Saamir Hassan; Peter Kim; Mehmet Cilingiroglu; Konstantinos Marmagkiolis; Biswajit Kar; Cezar Iliescu
Journal:  Curr Cardiol Rep       Date:  2019-07-08       Impact factor: 2.931

Review 2.  Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology.

Authors:  Jaidyn Muhandiramge; John R Zalcberg; G J van Londen; Erica T Warner; Prudence R Carr; Andrew Haydon; Suzanne G Orchard
Journal:  Curr Oncol Rep       Date:  2022-07-07       Impact factor: 5.075

Review 3.  Ten things to know about ten cardiovascular disease risk factors - 2022.

Authors:  Harold E Bays; Anandita Kulkarni; Charles German; Priyanka Satish; Adedapo Iluyomade; Ramzi Dudum; Aarti Thakkar; Mahmoud Al Rifai; Anurag Mehta; Aneesha Thobani; Yousif Al-Saiegh; Adam J Nelson; Samip Sheth; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2022-04-06

Review 4.  Interventional Strategies in Cancer-induced Cardiovascular Disease.

Authors:  Bala Pushparaji; Teodora Donisan; Dinu V Balanescu; Nicolas Palaskas; Peter Kim; Juan Lopez-Mattei; Mehmet Cilingiroglu; Saamir A Hassan; Konstantinos Dean Boudoulas; Konstantinos Marmagkiolis; Ludhmila Abrahao Hajjar; Cezar A Iliescu
Journal:  Curr Oncol Rep       Date:  2021-09-27       Impact factor: 5.075

Review 5.  Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity.

Authors:  Shuxu Du; Yaqian Huang; Hongfang Jin; Tianyou Wang
Journal:  Front Pharmacol       Date:  2018-01-26       Impact factor: 5.810

6.  Effect of continuation of antiplatelet therapy on survival in patients receiving physician home visits.

Authors:  Yasuhiro Osugi; Teruo Ino; Daiki Kobayashi; Mitsunaga Iwata; Kanichi Asai
Journal:  BMC Geriatr       Date:  2019-12-23       Impact factor: 3.921

7.  Association between the Severity of Coronary Artery Disease and Lung Cancer: A Pilot Cross-Sectional Study.

Authors:  Mingzhuang Sun; Qian Yang; Meng Li; Jing Jing; Hao Zhou; Yundai Chen; Shunying Hu
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

Review 8.  Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues.

Authors:  Roshni Bhatnagar; Neal M Dixit; Eric H Yang; Tamer Sallam
Journal:  Front Cardiovasc Med       Date:  2022-08-09

9.  An Association Rule Mining Analysis of Lifestyle Behavioral Risk Factors in Cancer Survivors with High Cardiovascular Disease Risk.

Authors:  Su Jung Lee; Kathleen B Cartmell
Journal:  J Pers Med       Date:  2021-05-02

Review 10.  Cardiac Restoration Stemming From the Placenta Tree: Insights From Fetal and Perinatal Cell Biology.

Authors:  Sveva Bollini; Antonietta R Silini; Asmita Banerjee; Susanne Wolbank; Carolina Balbi; Ornella Parolini
Journal:  Front Physiol       Date:  2018-04-11       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.